| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | 2.16.840.1.113762.1.4.1260.101 |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1260.101/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.101 |
| Version | 20240216 |
| Status | active |
| Date | 2024-02-16T01:10:57-05:00 |
| Name | SystemicCancerDirectedTherapy |
| Title | Systemic Cancer Directed Therapy |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: Systemic Cancer Medications),(Data Element Scope: Rxnorm codes),(Inclusion Criteria: All traditional cytotoxic chemotherapy (such as alkylating agents, antimetabolites, plant alkaloidsand terpenoids, topoisomerase inhibitors, and antitumor antibiotics); Immunotherapy; Biologics (such as Herceptin, Rituxan); and Targeted agents),(Exclusion Criteria: Supportive care therapies (e.g., growth factors, bisphosphonates, RANK ligand inhibitors, nausea medications or fluids if these are not given in association with “systemic cancer directed therapy”). Hormonal therapies and steroids are not included in this systemic cancer directed therapy definition.) |
No resources found
| CodeSystem | |
| rxnorm | RxNorm |
| rxnorm | RxNorm |
No narrative content found in resource
FHIR